Analytical and clinical evaluation of the bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: A multisite study

Clinical Chemistry

Volumn 50, Issue 5, 2004, Pages 867-873

  Wu, Alan H B ^a   Packer, Milton ^b   Smith, Andrew ^a   Bijou, Rachel ^b   Fink, Daniel ^b   Mair, Johannes ^c   Wallentin, Lars ^d   Johnston, Nina ^d   Feldcamp, Carolyn S ^e   Haverstick, Doris M ^f   Ahnadi, Charaf E ^g   Grant, Andrew ^g   Despres, Normand ^h   Bluestein, Barry ^h   Ghani, Farooq ^h  

^a HARTFORD HOSPITAL   (United States)

^b New York Presbyterian Hospital Columbia University Medical Center   (United States)

^c UNIVERSITY OF INNSBRUCK   (Austria)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^e HENRY FORD HOSPITAL   (United States)

^f UNIVERSITY OF VIRGINIA   (United States)

^g Ctr Res and Eval in Diagnostics   (Canada)

^h BAYER CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; ASSAY; AUTOMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; EVALUATION; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVER VARIATION; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; AUTOANALYSIS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; REFERENCE VALUES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 11144358465     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2003.026138     Document Type: Article

References (28)

1. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al., for the BNP Multinational Study Investigators. Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure: preliminary results from the Breathing Not Properly (BNP) Multinational Study. N Engl J Med 2002;347:161-7.
2. Campbell DJ, Munir V, Hennessy OF, Dent AW. Plasma amino-terminal pro-brain natriuretic peptide levels in subjects presenting to the emergency department with suspected acute coronary syndrome: possible role in selecting patients for follow up? Intern Med J 2001;31:211-9.
3. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Eur Heart J 2001;22:1527-60.
4. Wieczorek SJ, Hager D, Barry MB, Kearney L, Ferrier A, Wu AHB. Correlation of B-type natriuretic peptide (BNP) to the 6-minute walk test in systolic congestive heart failure patients. Clin Chim Acta 2003;328:87-90.
5. Wieczorek SJ, Wu AHB, Christenson R, Rosano T, Hager D, Bailly K, et al. A rapid B-type natriuretic peptide (BNP) assay accurately diagnoses left ventricular dysfunction and heart failure - a multicenter evaluation. Am Heart J 2002;144:834-9.
6. Kono M, Yamauchi A, Tsuju T, Misaki A, Igano K, Ueki K, et al. An immunoradiometric assay for brain natriuretic peptide in human plasma. Jpn J Nucl Med 1993;13:2-7.
7. National Committee for Clinical Laboratory Standards. Evaluation of precision performance of clinical chemistry devices; approved guideline. NCCLS guideline EP5A. Wayne, PA: NCCLS, 1999.
8. Wu AHB, Smith AC, Mather JF, Duncan B, White CM, Ahlberg A, et al. Biological variation for NT-pro- and B-type natriuretic peptides: implications for therapeutic monitoring of patients with heart failure. Am J Cardiol 2003;92:428-31.
9. Shan K, Lincoff AM, Young JB. Anthracycline-induced cardiotoxicity. Ann Intern Med 1996;125:47-58.
10. Sparano JA. Cardiac toxicity of trastuzumab (Herceptin): implications for the design of adjuvant trials. Semin Oncol 2001;28: 20-7.
11. Belenky A, Smith A, Zhangg B, Lin S, Despres N, Wu AH, et al. The effect of class specific protease inhibitors on the stabilization of B-type natriuretic peptide in human plasma. Clin Chim Acta 2004;340:163-72.
12. Yeo KTJ, Wu AHB, Apple FS, Kroll MH, Christenson RH, Lewandrowski KB, et al. Multicenter evaluation of the Roche NT-proBNP assay and comparison to Biosite Triage BNP assay. Clin Chim Acta 2003, 2003;338:107-15.
13. Fraser CG. Biological variation: from principles to practice. Washington, DC: AACC Press, 2001:46-7.
14. Shimizu H, Masuta K, Aono K, Asada H, Sasakura K, Tamaki M, et al. Molecular forms of human brain natriuretic peptide in plasma. Clin Chim Acta 2002;316:129-35.
15. Del Ry S, Giannessi D, Clerico A. Plasma brain natriuretic peptide measured by fully automated immunoassay and by immunoradiometric assay compared. Clin Chem Lab Med 2001;39:446-50.
16. Voegeser M, Jacob K. B type natriuretic peptide (BNP)-validation of an immediate response assay. Clin Lab 2001;47:29-33.
17. Fischer Y, Filzmaier K, Stiegler H, Graf J, Fuhs S, Franke A, et al. Evaluation of a new, rapid bedside test for quantitative determination of B-type natriuretic peptide. Clin Chem 2001;47:591-4.
18. Maisel AS, Koon J, Krishnaswamy P, Kazenegra R, Clopton P, Gardetto N, et al. Utility of B-type natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J 2001; 141:367-74.
19. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002;40:976-82.
20. Luchner A, Hengstenberg C, Lowel H, Trawinski J, Baumann M, Riegger GAJ, et al. N-Terminal pro-brain natriuretic peptide after myocardial infarction. A marker of cardio-renal function. Hypertension 2002;39:99-104.
21. American Heart Association. Heart disease and stroke statistics-2004 update. Dallas, TX: American Heart Association, 2002. http://www.americanheart. org/presenter.jhtm?identifier=1928.
22. McCullough PA, Duc P, Omland T, McCord J, Nowak RM Hollander JE, et al. B-Type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kid Dis 2003;41:571-9.
23. Mundy BJ, McCord J, Nowak RM, Hudson MP, Czerska B, Jacobsen G, et al., BNP Multinational Study Investigators. B-Type natriuretic peptide levels are inversely related to body mass index in patients with heart failure [Abstract]. J Am Coll Cardiol 2003; 41:158A.
24. Kuczmarski Rj, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults. JAMA 1994;272:205-11.
25. Biosite, Inc. Triage BNP package insert. San Diego, CA: Biosite Inc., 2002.
26. Bayer HealthCare LLC. ADVIA Centaur BNP package insert. Tarrytown, NY: Bayer HealthCare LLC, Diagnostics Division, 2003.
27. Roche Diagnostics. ProBNP package insert. Indianapolis, IN: Roche Diagnostics, 2002.
28. Maisel AS, Morrison K, Demaria AN. The use of B-natriuretic peptide (BNP) in assessing cardiac function in patients with diabetes mellitus [Abstract]. Circulation 2001;104(Suppl):11-3.